Adeno-associated virus (AAV) has emerged as a leading platform for gene delivery for
treating various diseases due to its excellent safety profile and efficient transduction to …

Instability of vaccines often emerges as a key challenge during clinical development (lab to
clinic) as well as commercial distribution (factory to patient). To yield stable, efficacious …

The global pharmaceutical market has recently shifted its focus from small molecule drugs to
peptide, protein, and nucleic acid drugs, which now comprise a majority of the top-selling …

Introduction Vaccines represent he most common and safer ways of combating infectious
diseases. Loss of potency owing to thermal denaturation or degradation of almost all the …

Once Covid-19 vaccines become available, 5–10 billion vaccine doses should be globally
distributed, stored and administered. In this commentary, we discuss how this enormous …

The development of vaccines against infectious diseases represents one of the most
important contributions to medical science. However, vaccine-preventable diseases still …

Up to 80% of the cost of vaccination programmes is due to the cold chain problem (that is,
keeping vaccines cold). Inexpensive, biocompatible additives to slow down the degradation …

The goal of this study is to develop thermostable microneedle patch formulations for
influenza vaccine that can be partially or completely removed from the cold chain. During …

Biomineralization refers to a native biosynthesis process whereby the organisms fabricate
hierarchical organic-inorganic composites for life maintenance, growth, and biological …

The ideal vaccine is a simple and stable formulation which can be conveniently
administered and provides life-long immunity against a given pathogen. The development of …